
Fostemsavir Tris
CAS No. 864953-39-9
Fostemsavir Tris( BMS-663068 Tris,FOSTEMSAVIR TROMETHAMINE )
Catalog No. M22849 CAS No. 864953-39-9
Fostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 78 | In Stock |
![]() ![]() |
5MG | 132 | In Stock |
![]() ![]() |
10MG | 196 | In Stock |
![]() ![]() |
25MG | 332 | In Stock |
![]() ![]() |
50MG | 489 | In Stock |
![]() ![]() |
100MG | 698 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameFostemsavir Tris
-
NoteResearch use only, not for human use.
-
Brief DescriptionFostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.
-
DescriptionFostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.BMS-663068 is the phosphonooxymethyl prodrug of BMS-626529, a novel small-molecule attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4(+) T cells.The activity of BMS-626529 is virus dependent, due to heterogeneity within gp120.?BMS-626529 had half-maximal effective concentration (EC(50)) values of <10 nM against the vast majority of viral isolates;?however, susceptibility varied by >6 log(10), with half-maximal effective concentration values in the low pM range against the most susceptible viruses.?The in vitro antiviral activity of BMS-626529 was generally not associated with either tropism or subtype, with few exceptions.?Measurement of the binding affinity of BMS-626529 for purified gp120 suggests that a contributory factor to its inhibitory potency may be a relatively long dissociative half-life.?(In Vivo):Fostemsavir Tris has good antiviral activity in subjects infected with virus shown to be susceptible (IC50, <100 nM) to the agent.
-
In Vitro——
-
In VivoFostemsavir Tris has good antiviral activity in subjects infected with virus shown to be susceptible (IC50, <100 nM) to the agent.
-
SynonymsBMS-663068 Tris,FOSTEMSAVIR TROMETHAMINE
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number864953-39-9
-
Formula Weight704.62
-
Molecular FormulaC29H37N8O11P
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (177.40 mM; Need ultrasonic); H2O:100 mg/mL (141.92 mM; Need ultrasonic)
-
SMILESO=C(N1CCN(C(C2=CC=CC=C2)=O)CC1)C(C3=CN(COP(O)(O)=O)C4=C3C(OC)=CN=C4N5N=C(C)N=C5)=O.OCC(CO)(N)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nowicka-Sans B, et al. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.
molnova catalog



related products
-
Escin IA;Aescin IA
Escin IA is a triterpene saponin isolated from horse chestnut which inhibits HIV-1 protease with IC50 values of 35 μM. Escin IA has anti-TNBC metastasis activity and its action mechanisms involved inhibition of epithelial-mesenchymal transition process by down-regulating LOXL2 expression.
-
Saquinavir
Apotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays.
-
Bictegravir
Bictegravir (GS 9883) is a novel potent HIV-1 integrase (IN) that specifically targets IN strand transfer activity with IC50 of 7.5 nM.